−52.3
Damora Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−42.9
FY23:
−36.9
FY24:
−18.6
FY25:
−6.73
Change from FY21 to FY25
millions USD
FY21:
−48.0
FY22:
12.4
FY23:
22.3
FY24:
11.7
FY25:
−17.4
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
0.51
FY23:
2.88
FY24:
–
FY25:
267
(positive)
Change from FY21 to FY22
millions USD
FY21:
−52.5
FY22:
−43.1
FY23:
–
FY24:
–
FY25:
–
All amounts in millions USD